Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury

Traumatic brain injury (TBI) is a major risk factor for several neurodegenerative disorders, including Parkinson’s disease (PD) and Alzheimer’s disease (AD). Neuroinflammation is a cause of later secondary cell death following TBI, has the potential to aggravate the initial impact, and provides a th...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Shih Chang Hsueh, Michael T. Scerba, David Tweedie, Daniela Lecca, Dong Seok Kim, Abdul Mannan Baig, Yu Kyung Kim, Inho Hwang, Sun Kim, Warren R. Selman, Barry J. Hoffer, Nigel H. Greig
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2022-09-01
Sarja:	Biomedicines
Aiheet:	pomalidomide immunomodulatory imide drugs (IMiDs) neuroinflammation traumatic brain injury cereblon
Linkit:	https://www.mdpi.com/2227-9059/10/10/2449
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!